4//SEC Filing
Bernard Thierry 4
Accession 0000950170-23-043001
CIK 0001492674other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:01 PM ET
Size
10.1 KB
Accession
0000950170-23-043001
Insider Transaction Report
Form 4
Bernard Thierry
Director
Transactions
- Exercise/Conversion
Common Stock
2023-08-06+454→ 5,022 total - Exercise/Conversion
Restricted Stock Units
2023-08-06−454→ 0 total→ Common Stock (454 underlying) - Exercise/Conversion
Restricted Stock Units
2023-01-01−1,550→ 0 total→ Common Stock (1,550 underlying) - Exercise/Conversion
Common Stock
2023-01-01+1,550→ 4,568 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]On January 1, 2022 the reporting person was granted 1,550 RSU's that vested in one installment on January 1, 2023.
- [F3]On August 6, 2020 the reporting person was granted 1,363 RSU's that vest in three equal annual installments beginning on August 6, 2021.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001815490
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:01 PM ET
- Size
- 10.1 KB